After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which ...

London based biotech Motif Bio PLC (LON:MTFB) just filed for a NASDAQ listing by way of an IPO in the US, and it’s drawing quite a lot of attention in the infectious disease space. The company’s ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Motif Bio (MTFB_old) Historical Data Assess MTFB_old UK share price history today. View the open price, closing price, historical highs, lows, changes and % change of the Motif Bio stock price for the ...

Motif Bio Plc (MTFB) is a biopharmaceutical company focused on the development of antibiotic compounds for difficult to treat bacterial infections. The company’s lead asset, iclaprim, is a novel ...

Health-care shares were mainly unchanged in pre-market trade on Tuesday. In health-care stocks news, Motif Bio plc ( MTFB) said Tuesday that REVIVE-1, the company's global phase 3 clinical trial of ...

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

(RTTNews) - The following are some of the healthcare stocks that hit new lows on Wednesday. Savara Inc. (SVRA), an orphan lung disease company, touched a new low of $1.01 on Wednesday before closing ...

(MENAFN- GlobeNewsWire - Nasdaq) itemprop="articleBody">NEW YORK, May22, 2019(GLOBE NEWSWIRE) -- Motif Bio plc (AIM/Nasdaq: MTFB), a clinical-stage biopharmaceutical company specialising in developing ...

On this page, you'll find detailed information about the financial performance of Motif Bio PLC, including the latest Motif Bio PLC earnings report and upcoming earnings date. The page provides an ...